10 results found.

Psoriatic Arthritis Clinical Trial using Tofacitinib; Placebo

Pfizer - Recruiting 18 years or older.
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One TNF Inhibitor.
Tofacitinib; Placebo

Psoriatic Arthritis Clinical Trial using golimumab; methotrexate

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) - Recruiting 18 years to 70 years.
- A Randomized, Double-blind, Placebo-controlled Trial of Golimumab+Methotrexate Versus Methotrexate Alone in Methotrexate-na‹ve Patients With Psoriatic Arthritis.
golimumab; methotrexate

Psoriatic Arthritis Clinical Trial using Tofacitinib 5 mg BID; Tofacitinib 10 mg BID; Adalimumab; Placebo

Pfizer - Recruiting 18 years or older.
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis.
Tofacitinib 5 mg BID; Tofacitinib 10 mg BID; Adalimumab; Placebo

Rheumatoid Arthritis, Ankylosing Spondylitis, Lupus Erythematosus Clinical Trial using Employment and Arthritis: Making it Work

University of British Columbia - Recruiting 18 years to 59 years.
- Employment and Arthritis: Making it Work: A Randomized Controlled Trial Evaluating an On-line Program to Help People With Inflammatory Arthritis Remain Employed.
Employment and Arthritis: Making it Work

Psoriasis, Arthritic Clinical Trial using ixekizumab; Placebo; Adalimumab

Eli Lilly and Company - Recruiting 18 years or older.
- A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients With Active Psoriatic Arthritis.
ixekizumab; Placebo; Adalimumab

Axial Spondyloarthritis (AxSpA), Non-radiographic Evidence-AxSpA, Clinical Trial using Blood draw from mother; Blood draw from infant; Blood draw from umbilical cord; Certolizumab Pegol

UCB, Inc. - Recruiting 18 years or older.
- A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimziar (Certolizumab Pegol) Phase 1b (Clinical Pharmacology).
Blood draw from mother; Blood draw from infant; Blood draw from umbilical cord; Certolizumab Pegol

Arthritis, Rheumatoid, Spondylitis, Ankylosing, or Arthritis, Pso Clinical Trial

Janssen Inc. - Recruiting N/A or older.
- BioTRAC (BIOLOGIC TREATMENT REGISTRY ACROSS CANADA) Rheumatology (Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis).

Psoriatic Arthritis Clinical Trial

AbbVie - Recruiting 18 years or older.
- Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (Complete- PsA).

Ankylosing Spondylitis, or Psoriatic Arthritis Clinical Trial

AbbVie - Recruiting 18 years to 50 years.
- Observational Study in AS and PsA Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium.

Rheumatoid Arthritis, Ankylosing Spondylitis, or Psoriatic Arthri Clinical Trial

AbbVie - Recruiting 18 years or older.
- Assessment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patient`s Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice.